aPODD - accelerating Pardiatric Oncology Drug Development Logo

24 December 2016

More ambitious collaborative models are needed - Open Letter

We often hear from childhood cancer charities calls for deeper and wider collaborations among key stakeholders. I fully agree that collaborations are beneficial but I do feel that we must further elaborate on this concept and focus more on outcomes other than procedures. We also need to challenge existing models and explore new ones.  One of the most puzzling observation I made when I set up aPODD and joined the childhood cancer community is how fragmented this community is and how...
read more

19 November 2016

Thanking our Crowdfunding Campaign Donors

We would like to thank warmly all the people that very kindly donated to our crowdfunding campaign for childhood brain cancer over the summer. It’s been a very exciting and rewarding experience! We are very pleased to confirm that, even though we did not hit our original fundraising targets, we managed to increase our international visibility and to receive some off-line donations during the campaign. As a result, we have raised sufficient funds to be able to run the first stage...
read more

20 October 2016

Kids Cancer ACT NOW launched to accelerate treatments for children with cancer

MRC Technology, a medical research charity, and aPODD, a childhood cancer charity, have launched a call to action to accelerate the development of new treatments for children with cancer. Around 1,500 children are diagnosed with cancer in the UK every year, and 300 will die from the disease. Cancer is the major cause of death by disease for children under 14 years of age in Europe and North America. Through Kids Cancer – ACT NOW, the charities are galvanising support from other...
read more

17 October 2016

The hunt for a new treatment for Neuroblastoma

A new project has been launched with the goal of identifying a potential new treatment for neuroblastoma, a type of cancer that it prevalent in children and adolescents. Neuroblastoma is the most common solid tumour occurring in children, with the exception of brain tumours. This disease can be particularly aggressive and quickly become resistant to conventional therapies, leading to a large number of deaths every year. New therapeutic options are urgently needed offering an alternative to...
read more

28 May 2016

PLEASE SUPPORT OUR CROWDFUNDING CAMPAIGN

We are raising funds to identify a new treatment for Medulloblastoma.

Please DONATE!

paediatric oncology facts

Childhood cancers statistics

Cancer is the leading cause of death by disease for children in the developed world, with the global incidence projected to increase dramatically over the next decades. Despite cure rates of 70-80% for many cancers, a subset of patients still face a very poor prognosis.

read more